Glad to have a visit from GTFCC and RDC MoH!

If you're interested in what epidemiological insights we can obtain from serological data, this is a must-read by James Hay @IsobelRoutledge Saki Takahashi: osf.io/kqdsn/

📢 IVI and EuBiologics are thrilled to announce that Euvichol-S, a simplified formulation of Euvichol-Plus® oral cholera vaccine, prequalified by World Health Organization (WHO), has been licensed for export by the Korean Ministry of Food and Drug Safety. ivi.int/euvichol-s-sim…

Thrilled to see our work coming out in the The Lancet Infectious Diseases . Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study -"thelancet.com/journals/lanin…

Nice thread on new evidence on 1-dose protection from #cholera #vaccine and the current global supply context.

👏🏽Here the 1st research paper PLOS NTDs on the 1st mass vaccination campaign against hepatitis E, which took place in the Bentiu camp in South Sudan 🇸🇸 It shows high vaccination coverage and few mild adverse events after vaccination. MSF Science andrew azman @andrewazman.bsky.social journals.plos.org/plosntds/artic…

While #cholera rages in many countries, there isn't any single dose of oral cholera vaccine left today in the emergency stockpile. (source: unicef.org/supply/documen…) #VaccinesWork

1/ Our latest work on #cholera burden in an endemic region in Bangladesh in Nature Medicine with icddr,b and Dr Firdausi Qadri andrew azman @andrewazman.bsky.social Javier Perez-Saez. rdcu.be/dy7iY

Integrated analysis of clinical, serological and behavioral data estimate that current clinical surveillance systems only detect 1 out of 3,280 true community infections in a cholera-endemic region of Bangladesh nature.com/articles/s4159…

Have some microbiology skills and want to work with us on a fun cholera project?

Our Centre has a new direction: Prof. Isabella Eckerle is the new director & Dr. Pauline Vetter the new deputy director of the Centre for Emerging Viral Diseases! Congratulations - to a bright future where we're one step ahead of emerging viruses! HUG Université de Genève MIMOL_UNIGE

Nous recherchons un scientifique motivé pour aider à gérer une étude à Uvira en RDC sur l'épidémiologie du #choléra et l'impact des #vaccins avec London School of Hygiene & Tropical Medicine JHIDDynamics CTDGH Temple University Laboratoire Rodolphe Mérieux Inrb Goma. Veuillez m'envoyer un message direct ou email pour plus de détails.

We are looking for a #consultant to develop, implement & validate #diagnostic assays for emerging viruses Geneva Centre for Emerging Viral Diseases. Required: Solid background in virology & diagnostics, work experience in LMICs, willingness to work internationally & French & English. DM me! #mpox #H5N1 #SARSCoV2

Today, I shared insights on the Mpox outbreak and its management challenges in Uvira, eastern 🇨🇩, at the Geneva Centre for Emerging Viral Diseases's monthly Medical Colloquium. Key issues include lack of lab capacity, insufficient contact tracing, community engagement and vaccine confidence. #Mpox #PublicHealth